Annual gross profit:
$35.67B+$7.15B(+25.05%)Summary
- As of today (April 12, 2025), NVO annual gross profit is $35.67 billion, with the most recent change of +$7.15 billion (+25.05%) on December 31, 2024.
- During the last 3 years, NVO annual gross profit has risen by +$17.03 billion (+91.39%).
- NVO annual gross profit is now at all-time high.
Performance
NVO Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$10.38B+$1.54B(+17.41%)Summary
- As of today (April 12, 2025), NVO quarterly gross profit is $10.38 billion, with the most recent change of +$1.54 billion (+17.41%) on December 31, 2024.
- Over the past year, NVO quarterly gross profit has stayed the same.
- NVO quarterly gross profit is now at all-time high.
Performance
NVO quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$35.64B+$2.32B(+6.97%)Summary
- As of today (April 12, 2025), NVO TTM gross profit is $35.64 billion, with the most recent change of +$2.32 billion (+6.97%) on December 31, 2024.
- Over the past year, NVO TTM gross profit has stayed the same.
- NVO TTM gross profit is now at all-time high.
Performance
NVO TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
NVO Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.1% | 0.0% | 0.0% |
| 3 y3 years | +91.4% | +110.3% | +91.4% |
| 5 y5 years | +133.4% | +159.5% | +126.3% |
NVO Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.4% | at high | +106.0% | at high | +83.9% |
| 5 y | 5-year | at high | +133.4% | at high | +178.6% | at high | +127.2% |
| alltime | all time | at high | >+9999.0% | at high | +1220.1% | at high | +4431.7% |
Novo Nordisk A/S Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $35.67B(+25.0%) | $10.38B(+17.4%) | $35.64B(+7.0%) |
| Sep 2024 | - | $8.84B(+6.0%) | $33.32B(+5.3%) |
| Jun 2024 | - | $8.34B(+3.3%) | $31.63B(+5.2%) |
| Mar 2024 | - | $8.07B(+0.2%) | $30.08B(+5.5%) |
| Dec 2023 | $28.53B(+35.5%) | $8.06B(+12.6%) | $28.52B(+10.0%) |
| Sep 2023 | - | $7.16B(+5.5%) | $25.94B(+8.2%) |
| Jun 2023 | - | $6.79B(+4.2%) | $23.97B(+7.9%) |
| Mar 2023 | - | $6.52B(+19.0%) | $22.22B(+5.8%) |
| Dec 2022 | $21.05B(+12.9%) | $5.48B(+5.4%) | $21.01B(+2.6%) |
| Sep 2022 | - | $5.19B(+3.1%) | $20.47B(+2.5%) |
| Jun 2022 | - | $5.04B(-4.9%) | $19.96B(+3.0%) |
| Mar 2022 | - | $5.30B(+7.3%) | $19.38B(+4.1%) |
| Dec 2021 | $18.64B(+14.8%) | $4.94B(+5.3%) | $18.62B(+3.8%) |
| Sep 2021 | - | $4.69B(+5.2%) | $17.93B(+3.7%) |
| Jun 2021 | - | $4.46B(-1.8%) | $17.29B(+4.4%) |
| Mar 2021 | - | $4.54B(+6.8%) | $16.56B(+2.0%) |
| Dec 2020 | $16.24B(+6.3%) | $4.25B(+4.9%) | $16.23B(+1.5%) |
| Sep 2020 | - | $4.05B(+8.6%) | $15.98B(+1.9%) |
| Jun 2020 | - | $3.73B(-11.4%) | $15.69B(-0.4%) |
| Mar 2020 | - | $4.21B(+5.1%) | $15.75B(+3.1%) |
| Dec 2019 | $15.28B(+2.4%) | $4.00B(+6.6%) | $15.28B(+1.1%) |
| Sep 2019 | - | $3.75B(-0.9%) | $15.12B(+0.8%) |
| Jun 2019 | - | $3.79B(+1.4%) | $15.00B(+0.6%) |
| Mar 2019 | - | $3.74B(-2.5%) | $14.91B(-0.1%) |
| Dec 2018 | $14.92B(+4.2%) | $3.83B(+5.3%) | $14.92B(+1.0%) |
| Sep 2018 | - | $3.64B(-1.4%) | $14.77B(+0.8%) |
| Jun 2018 | - | $3.69B(-1.5%) | $14.66B(+0.8%) |
| Mar 2018 | - | $3.75B(+1.8%) | $14.55B(+2.0%) |
| Dec 2017 | $14.32B(+1.8%) | $3.69B(+4.4%) | $14.27B(+0.8%) |
| Sep 2017 | - | $3.53B(-1.4%) | $14.16B(-0.0%) |
| Jun 2017 | - | $3.58B(+3.3%) | $14.16B(+0.2%) |
| Mar 2017 | - | $3.47B(-3.0%) | $14.13B(+0.5%) |
| Dec 2016 | $14.06B(+3.0%) | $3.57B(+1.2%) | $14.06B(+0.1%) |
| Sep 2016 | - | $3.53B(-0.7%) | $14.04B(+0.8%) |
| Jun 2016 | - | $3.55B(+4.6%) | $13.93B(+0.9%) |
| Mar 2016 | - | $3.40B(-4.5%) | $13.81B(+1.2%) |
| Dec 2015 | $13.65B(+3.1%) | $3.56B(+4.1%) | $13.64B(+0.8%) |
| Sep 2015 | - | $3.42B(-0.5%) | $13.54B(+0.5%) |
| Jun 2015 | - | $3.44B(+6.4%) | $13.47B(+1.0%) |
| Mar 2015 | - | $3.23B(-6.5%) | $13.33B(+1.0%) |
| Dec 2014 | $13.24B(+7.1%) | $3.45B(+3.2%) | $13.20B(+0.9%) |
| Sep 2014 | - | $3.35B(+1.4%) | $13.08B(+2.6%) |
| Jun 2014 | - | $3.30B(+6.5%) | $12.76B(+1.5%) |
| Mar 2014 | - | $3.10B(-7.2%) | $12.57B(+1.6%) |
| Dec 2013 | $12.36B(+10.9%) | $3.34B(+10.6%) | $12.37B(+2.0%) |
| Sep 2013 | - | $3.02B(-3.0%) | $12.13B(+2.3%) |
| Jun 2013 | - | $3.11B(+7.5%) | $11.85B(+3.0%) |
| Mar 2013 | - | $2.90B(-6.4%) | $11.51B(+3.3%) |
| Dec 2012 | $11.15B(+11.0%) | $3.10B(+12.7%) | $11.14B(+3.5%) |
| Sep 2012 | - | $2.75B(-0.9%) | $10.76B(+2.2%) |
| Jun 2012 | - | $2.77B(+9.5%) | $10.54B(+2.7%) |
| Mar 2012 | - | $2.53B(-6.8%) | $10.25B(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $10.04B(+14.9%) | $2.72B(+7.8%) | $10.03B(+3.5%) |
| Sep 2011 | - | $2.52B(+1.2%) | $9.69B(+3.5%) |
| Jun 2011 | - | $2.49B(+7.9%) | $9.36B(+4.1%) |
| Mar 2011 | - | $2.31B(-2.8%) | $9.00B(+3.0%) |
| Dec 2010 | $8.74B(+14.9%) | $2.37B(+8.3%) | $8.73B(+3.6%) |
| Sep 2010 | - | $2.19B(+3.3%) | $8.43B(+3.7%) |
| Jun 2010 | - | $2.12B(+3.9%) | $8.12B(+2.8%) |
| Mar 2010 | - | $2.04B(-1.3%) | $7.90B(+3.8%) |
| Dec 2009 | $7.61B(+8.7%) | $2.07B(+9.6%) | $7.61B(+3.8%) |
| Sep 2009 | - | $1.89B(-0.7%) | $7.33B(+2.1%) |
| Jun 2009 | - | $1.90B(+8.6%) | $7.18B(+1.5%) |
| Mar 2009 | - | $1.75B(-2.2%) | $7.07B(+1.5%) |
| Dec 2008 | $7.00B(+18.6%) | $1.79B(+3.0%) | $6.97B(+2.3%) |
| Sep 2008 | - | $1.74B(-3.0%) | $6.81B(+4.0%) |
| Jun 2008 | - | $1.79B(+8.8%) | $6.55B(+4.9%) |
| Mar 2008 | - | $1.65B(+1.0%) | $6.24B(+5.6%) |
| Dec 2007 | $5.90B(+20.1%) | $1.63B(+10.7%) | $5.91B(+4.7%) |
| Sep 2007 | - | $1.48B(-0.7%) | $5.64B(+4.4%) |
| Jun 2007 | - | $1.49B(+12.7%) | $5.41B(+4.3%) |
| Mar 2007 | - | $1.32B(-3.6%) | $5.18B(+5.4%) |
| Dec 2006 | $4.91B(+19.8%) | $1.37B(+10.4%) | $4.92B(+5.8%) |
| Sep 2006 | - | $1.24B(-1.8%) | $4.65B(+4.2%) |
| Jun 2006 | - | $1.26B(+19.6%) | $4.46B(+5.6%) |
| Mar 2006 | - | $1.05B(-3.9%) | $4.23B(+3.5%) |
| Dec 2005 | $4.10B(+16.0%) | $1.10B(+4.2%) | $4.09B(+1.4%) |
| Sep 2005 | - | $1.05B(+2.6%) | $4.03B(+4.7%) |
| Jun 2005 | - | $1.03B(+12.4%) | $3.85B(+4.9%) |
| Mar 2005 | - | $912.77M(-12.3%) | $3.67B(+3.6%) |
| Dec 2004 | $3.53B(+21.2%) | $1.04B(+19.2%) | $3.55B(+41.5%) |
| Sep 2004 | - | $873.13M(+3.2%) | $2.51B(+53.5%) |
| Jun 2004 | - | $845.81M(+7.5%) | $1.63B(+107.5%) |
| Mar 2004 | - | $786.46M | $786.46M |
| Dec 2003 | $2.92B(+23.6%) | - | - |
| Dec 2002 | $2.36B(+10.5%) | - | - |
| Dec 2001 | $2.13B(+4.7%) | - | - |
| Dec 2000 | $2.04B(+10.9%) | - | - |
| Dec 1999 | $1.84B(+17.8%) | - | - |
| Dec 1998 | $1.56B(-16.2%) | - | - |
| Dec 1997 | $1.86B(+0.4%) | - | - |
| Dec 1996 | $1.85B(+4.9%) | - | - |
| Dec 1995 | $1.77B(+15.7%) | - | - |
| Dec 1994 | $1.53B(+46.7%) | - | - |
| Dec 1993 | $1.04B(-23.0%) | - | - |
| Dec 1992 | $1.35B(+71.3%) | - | - |
| Dec 1991 | $789.15M(+15.8%) | - | - |
| Dec 1990 | $681.45M(+29.0%) | - | - |
| Dec 1989 | $528.06M(+21.8%) | - | - |
| Dec 1988 | $433.72M(+21.6%) | - | - |
| Dec 1987 | $356.81M(+222.1%) | - | - |
| Dec 1986 | $110.76M(-44.2%) | - | - |
| Dec 1985 | $198.34M(+17.0%) | - | - |
| Dec 1984 | $169.47M | - | - |
FAQ
- What is Novo Nordisk A/S annual gross profit?
- What is the all time high annual gross profit for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual gross profit year-on-year change?
- What is Novo Nordisk A/S quarterly gross profit?
- What is the all time high quarterly gross profit for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly gross profit year-on-year change?
- What is Novo Nordisk A/S TTM gross profit?
- What is the all time high TTM gross profit for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM gross profit year-on-year change?
What is Novo Nordisk A/S annual gross profit?
The current annual gross profit of NVO is $35.67B
What is the all time high annual gross profit for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual gross profit is $35.67B
What is Novo Nordisk A/S annual gross profit year-on-year change?
Over the past year, NVO annual gross profit has changed by +$7.15B (+25.05%)
What is Novo Nordisk A/S quarterly gross profit?
The current quarterly gross profit of NVO is $10.38B
What is the all time high quarterly gross profit for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly gross profit is $10.38B
What is Novo Nordisk A/S quarterly gross profit year-on-year change?
Over the past year, NVO quarterly gross profit has changed by $0.00 (0.00%)
What is Novo Nordisk A/S TTM gross profit?
The current TTM gross profit of NVO is $35.64B
What is the all time high TTM gross profit for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM gross profit is $35.64B
What is Novo Nordisk A/S TTM gross profit year-on-year change?
Over the past year, NVO TTM gross profit has changed by $0.00 (0.00%)